Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) rose sharply in today's pre-market trading after the company confirmed the receipt of Biogen’s nonbinding $7.22/share acquisition proposal.
Sage Therapeutics shares jumped 34.2% to $7.45 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
